LigaTrap specializes in advanced purification technologies, particularly focusing on affinity chromatography resins designed for the efficient separation of antibodies and other biomolecules. Their flagship products include LigaGuard, a proprietary absorbent technology that utilizes a combination of multi-modal ligands to selectively capture host cell proteins (HCPs) and DNA in a continuous flow-through mode. This innovative approach allows for high purity and recovery of desired bio-products while enabling unbound materials to progress through the purification process. Additionally, LigaTrap offers AAVidity, an affinity resin that facilitates the serotype-agnostic purification of adeno-associated viruses (AAVs) from various lysates, ensuring excellent binding capacity and contaminant clearance.

The company also provides a versatile Base Resin engineered for the purification of high-quality antibodies, including IgG, IgA, and IgY from diverse sources. LigaTrap's Base Resin boasts impressive binding capacities and purity levels, significantly outperforming traditional Protein A and G resins. The technology is designed to be user-friendly, with mild elution conditions that preserve the functionality of the antibodies, and it can be reused multiple times after sanitization. Overall, LigaTrap's commitment to high-quality purification solutions positions it as a leader in the biotechnology sector, catering to the needs of researchers and developers in the field.

United States

LigaTrap has developeda patented portfolio of affinity ligands that can be used to purifymonoclonal and polyclonal immunoglobulins from various species.

LigaTrap

Company Details